Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

The Plateau of BCR-ABL Transcript Level ≥0.1% May Select CML Patients in Complete Cytogenetic Remission for Mutation Analysis.

Katerina Machova Polakova, Vaclava Polivkova, Jana Rulcova, Hana Klamova, Tomas Jurcek, Dana Dvorakova, Daniela Zackova, Zdenek Pospisil, Jirí Mayer, Jana Moravcova

Blood (2009) 114 (22): 2216.

https://doi.org/10.1182/blood.V114.22.2216.2216

Published: 2009

Journal Articles

New Characteristics of Liver Gvhd: Kinetics, and the Serum Levels of Enzymes Linked to Cholestasis

Jiri Mayer, MD, Jan Kamelander, MD, Zdenek Pospisil, MSc, Michael Doubek, MD, PhD, Marta Krejci, MD, PhD

Blood (2008) 112 (11): 4359.

https://doi.org/10.1182/blood.V112.11.4359.4359

Published: 2008

Journal Articles

Detection and Treatment of Molecular Relapse in Acute Myeloid Leukemia with RUNX1, CBFB or MLL Gene Translocations. Frequent Quantitative Monitoring of Molecular Markers in Different Compartments and Correlation with WT1 Gene Expression.

Michael Doubek, MD, PhD, Ivo Palasek, MD, Zdenek Pospisil, PhD, Sona Struncova, PhD, Dana Dvorakova, PhD, Marek Borsky, PhD, Martin Klabusay, PhD, Yvona Brychtova, MD, Marta Krejci, MD, PhD, Jiri Mayer, MD, PhD

Blood (2007) 110 (11): 4356.

https://doi.org/10.1182/blood.V110.11.4356.4356

Published: 2007

Journal Articles

Detection of Molecular Relapse of AML by Very Frequent Quantitative Monitoring of Different Molecular Markers (Fusion Transcripts and WT1) in Different Compartments (Peripheral Blood-PB, Bone Marrow-BM, and Selected CD34+ Bone Marrow Cells) and Its Treatment with Chemotherapy or Gemtuzumab Ozogamicin.

Jiri Mayer, Ivo Palasek, Zdenek Pospisil, Sona Struncova, Dana Dvorakova, Marek Borsky, Martin Klabusay, Michael Doubek, Yvona Brychtova, Zdenek Racil

Blood (2006) 108 (11): 4481.

https://doi.org/10.1182/blood.V108.11.4481.4481

Published: 2006

Journal Articles

Rituximab Sensitizes B-CLL Cells with Inactivated p53 to Fludarabine.

Martin Trbusek, Sona Cejkova, MSc, Jitka Chumchalova, Zdenek Pospisil, PhD, Jana Smardova, Petr Kuglik, Michael Doubek, MD, PhD, Yvona Brychtova, MD, Sarka Pospisilova, PhD, Jiri Mayer, MD

Blood (2006) 108 (11): 4973.

https://doi.org/10.1182/blood.V108.11.4973.4973

Published: 2006

NARROW

The Plateau of BCR-ABL Transcript Level ≥0.1% May Select CML Patients in Complete Cytogenetic Remission for Mutation Analysis.

New Characteristics of Liver Gvhd: Kinetics, and the Serum Levels of Enzymes Linked to Cholestasis

Detection and Treatment of Molecular Relapse in Acute Myeloid Leukemia with RUNX1, CBFB or MLL Gene Translocations. Frequent Quantitative Monitoring of Molecular Markers in Different Compartments and Correlation with WT1 Gene Expression.

Rituximab Sensitizes B-CLL Cells with Inactivated p53 to Fludarabine.

Email alerts

ASH Publications

American Society of Hematology

The Plateau of BCR-ABL Transcript Level ≥0.1% May Select CML Patients in Complete Cytogenetic Remission for Mutation Analysis.

New Characteristics of Liver Gvhd: Kinetics, and the Serum Levels of Enzymes Linked to Cholestasis

Detection and Treatment of Molecular Relapse in Acute Myeloid Leukemia with RUNX1, CBFB or MLL Gene Translocations. Frequent Quantitative Monitoring of Molecular Markers in Different Compartments and Correlation with WT1 Gene Expression.

Rituximab Sensitizes B-CLL Cells with Inactivated p53 to Fludarabine.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only